Cargando…

Lactate induces PD-L1 in HRAS(G12V)-positive oropharyngeal squamous cell carcinoma

Intratumoral lactate production negatively correlates with survival and tumor clearance in the setting of human papillomavirus positive oropharyngeal squamous cell carcinoma (HPV-positive OPSCC). Robust anti-tumor immune activity is required for tumor clearance in human patients and animal models of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Alexander K., Messerli, Shanta M., Miskimins, W. Keith
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7197448/ https://www.ncbi.nlm.nih.gov/pubmed/32391119 http://dx.doi.org/10.18632/oncotarget.27348

Ejemplares similares

PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma
por: Chiosea, Simion I, et al.
Publicado: (2013)

Tipifarnib in Head and Neck Squamous Cell Carcinoma With HRAS Mutations
por: Ho, Alan L., et al.
Publicado: (2021)

Somatic HRAS p.G12S Mutation Causes Woolly Hair and Epidermal Nevi
por: Levinsohn, Jonathan L., et al.
Publicado: (2013)

Differences in PD-L1 Expression between oral and oropharyngeal squamous cell carcinoma
por: Blatt, Sebastian, et al.
Publicado: (2022)

Association Between PD-L1 and HPV Status and the Prognostic Value of PD-L1 in Oropharyngeal Squamous Cell Carcinoma
por: Kim, Hae Su, et al.
Publicado: (2016)

Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression
por: Zhuang, Yongxian, et al.
Publicado: (2023)

Comparison of PD-L1 expression in squamous cell cancer of unknown primary and oropharyngeal squamous cell carcinoma
por: Schmidl, Benedikt, et al.
Publicado: (2022)

Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression
por: Xu, Sheng-ming, et al.
Publicado: (2022)

Increased PD-L1 and p16 expression are common in oropharyngeal squamous cell carcinoma
por: Shestakova, Anna, et al.
Publicado: (2021)

Metabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic mice
por: Fan, Tingting, et al.
Publicado: (2017)

Reduced HRAS(G12V)-Driven Tumorigenesis of Cell Lines Expressing KRAS(C118S)
por: Huang, Lu, et al.
Publicado: (2015)

Increased osteoclastogenesis contributes to bone loss in the Costello syndrome Hras G12V mouse model
por: Nandi, Sayantan, et al.
Publicado: (2022)

Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck
por: Sasaki, Eiichi, et al.
Publicado: (2020)

HRAS Mutations Define a Distinct Subgroup in Head and Neck Squamous Cell Carcinoma
por: Coleman, Niamh, et al.
Publicado: (2023)

Spatial proximity between T and PD-L1 expressing cells as a prognostic biomarker for oropharyngeal squamous cell carcinoma
por: Tsakiroglou, Anna Maria, et al.
Publicado: (2019)

Prognostic Significance of PD-L1 Expression In Patients With Primary Oropharyngeal Squamous Cell Carcinoma: A Meta-Analysis
por: Polesel, Jerry, et al.
Publicado: (2021)

Establishment of HRAS(G12V) Transgenic Medaka as a Stable Tumor Model for In Vivo Screening of Anticancer Drugs
por: Matsuzaki, Yuriko, et al.
Publicado: (2013)

Transformation by Hras(G12V) is Consistently Associated with Mutant Allele Copy Gains and is Reversed by Farnesyl Transferase Inhibition
por: Chen, Xu, et al.
Publicado: (2013)

Costello syndrome with special cutaneous manifestations and HRAS G12D mutation: A case report and literature review
por: Qian, Wen, et al.
Publicado: (2021)

Expression of oncogenic HRAS (G12V) causes defects in control of cell size in NIH 3T3 cells
por: DeWitt, Jerry T., et al.
Publicado: (2023)

LEF1/Id3/HRAS axis promotes the tumorigenesis and progression of esophageal squamous cell carcinoma
por: Wang, Xinyu, et al.
Publicado: (2020)

Induction Chemotherapy for p16 Positive Oropharyngeal Squamous Cell Carcinoma
por: Saito, Yuki, et al.
Publicado: (2016)

Educational Case: Human Papillomavirus–Positive Oropharyngeal Squamous Cell Carcinoma
por: Shen, Minqian, et al.
Publicado: (2019)

A case of woolly hair nevus, multiple linear pigmentation, and epidermal nevi with somatic HRAS p.G12S mutation
por: Nishihara, Katsuhiko, et al.
Publicado: (2019)

PD-L1 Expression and a High Tumor Infiltrate of CD8+ Lymphocytes Predict Outcome in Patients with Oropharyngeal Squamous Cells Carcinoma
por: Wuerdemann, Nora, et al.
Publicado: (2020)

Prognostic impact of p16 and PD-L1 expression in patients with oropharyngeal squamous cell carcinoma receiving a definitive treatment
por: Sato, Fumihiko, et al.
Publicado: (2019)

Editorial: Considerations in the surgical management of HPV-positive oropharyngeal squamous cell carcinoma
por: Mallen-St Clair, Jon, et al.
Publicado: (2023)

Costello syndrome model mice with a Hras(G12S/+) mutation are susceptible to develop house dust mite-induced atopic dermatitis
por: Katata, Yu, et al.
Publicado: (2020)

PD-L1 expression is associated with p16(INK4A) expression in non-oropharyngeal head and neck squamous cell carcinoma
por: Chen, San-Chi, et al.
Publicado: (2018)

CD8+ T Cells and PD-L1 Expression as Prognostic Indicators in a Low Prevalence of HPV-Associated Oropharyngeal Squamous Cell Carcinoma
por: Atipas, Kawita, et al.
Publicado: (2023)

HPV+ cancer cell lactate production attenuates immune response during treatment: lactate production inhibition leads to improved long-term cures
por: Zhuang, Cathy, et al.
Publicado: (2012)

A Case of Apocrine Carcinoma Arising in a Sebaceous Naevus: Detection of HRAS G13R Mutation
por: KATSUIE, Shiho, et al.
Publicado: (2022)

Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
por: Lyu, Haoyu, et al.
Publicado: (2019)

G4-DNA Formation in the HRAS Promoter and Rational Design of Decoy Oligonucleotides for Cancer Therapy
por: Membrino, Alexandro, et al.
Publicado: (2011)

MAPK activation and HRAS mutation identified in pituitary spindle cell oncocytoma
por: Miller, Michael B., et al.
Publicado: (2016)

Validation of a novel diagnostic standard in HPV-positive oropharyngeal squamous cell carcinoma
por: Schache, A G, et al.
Publicado: (2013)

Emerging Trends in the Pathological Research of Human Papillomavirus-positive Oropharyngeal Squamous Cell Carcinoma
por: Crane, Joshua, et al.
Publicado: (2022)

Oral health in HPV-positive and HPV-negative patients with oropharyngeal squamous cell carcinoma
por: Kanzow, Philipp, et al.
Publicado: (2023)

An Update on the Immunotherapy for Oropharyngeal Squamous Cell Carcinoma
por: Huang, Yaxuan, et al.
Publicado: (2022)

Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer
por: Messerli, Shanta M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oej2j7ak3nnej4d6trq04d0vcv